LexDanaLexDanabeta
Inventor

JINMING GU

Inventor
CN

Overview

3→
Patents
2022–2023
Patent span
Human necessities
Primary field (CPC A)

Patents· 3 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07KPeptides25%
G01NInvestigating or analysing materials by determining their chemical or physical properties17%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms8%
PatentTitleYear
11,680,100B7-H3 antibody, antigen-binding fragment thereof and medical use thereof202311,359,021PD-L1 antibody, antigen-binding fragment thereof, and pharmaceutical use thereof202211,274,142Fusion protein containing TGF-b receptor and medicinal uses thereof2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022Patents assigned to JIANGSU HENGRUI MEDICINE CO (2)· patent assignee history
2022Patents assigned to Shanghai hengrui pharmaceutical co ltd (2)· patent assignee history
2022–2023Based in CN· patent location history
2023Patents assigned to CHANGZHOU HANSOH PHARMACEUTICAL CO LTD (1)· patent assignee history
2023Patents assigned to HANSOH SHANGHAI HEALTHTECH CO LTD (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
JIANGSU HENGRUI MEDICINE CO22022
Shanghai hengrui pharmaceutical co ltd22022
CHANGZHOU HANSOH PHARMACEUTICAL CO LTD12023
HANSOH SHANGHAI HEALTHTECH CO LTD12023
Locations
LocationPatentsSpan
CN32022–2023